State Street’s Alpha Tau Medical DRTS Stock Holding History

State Street’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.34M	Buy	+90,200	New	+$1.24M	﹤0.01%	3491

Other funds holding DRTS

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return

Mariner Overland Park, Kansas $100B AUM 26.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $189B AUM 37.1% 1-Year Est. Return

Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return

Levin Capital Strategies New York $1.42B AUM 19.05% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return

State Street's DRTS Position: Q3 2026 in Review

State Street opened a new position in Alpha Tau Medical (DRTS) in Q3 2026: 90,200 shares worth $1.34M. The stake represents ﹤0.01% of the portfolio and ranks #3491 among its holdings.

38 funds tracked by Wall St. Rank hold DRTS as of Q3 2026.

State Street held 90,200 shares of Alpha Tau Medical worth $1.34M as of Q3 2026.
Alpha Tau Medical was a new State Street position in Q3 2026.
Alpha Tau Medical made up ﹤0.01% of State Street's portfolio in Q3 2026, its #3491 holding.
38 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.